Radiation Oncology Market Size and Share Analysis: Opportunities for Cancer Care Equipment Manufacturers

By Technology

Key technologies include IGRT, IMRT, stereotactic radiotherapy, proton beam radiotherapy, three-dimensional conformal radiation therapy (3D-CRT), VMAT, and brachytherapy. IMRT adjusts radiation intensity to shape the dose around the tumor and help limit exposure to nearby healthy tissues. IGRT uses imaging to support accurate targeting, while stereotactic approaches deliver highly focused radiation to specific targets.

Proton therapy is another important technology because it offers different dose-delivery characteristics compared with conventional photon-based treatment. Adoption of each technology depends on clinical suitability, infrastructure, investment requirements, and the availability of trained personnel.

By Application and End User

Radiation oncology is used to treat several cancer types, including prostate, breast, lung, head and neck, colorectal, and gynecologic cancers. Treatment choice depends on the patient's diagnosis and the clinical team's assessment.

Hospitals and clinics, specialized cancer treatment centers, and research institutes are the key end-user categories. Hospitals and dedicated cancer centers require radiation systems to deliver treatment, while research institutes contribute to the evaluation and development of new approaches. Demand from these organizations is influenced by cancer-care needs, equipment budgets, clinical capabilities, and access to qualified professionals.

Regional Insights

North America

North America held the largest share of the global radiation oncology market in 2025, accounting for 39.2% of the market. The region benefits from established healthcare infrastructure, relatively high healthcare expenditure, and access to advanced medical technologies. The growing need for cancer treatment, an aging population, government support, and the presence of professional organizations also contribute to market development.

Organizations such as the American Society for Radiation Oncology support professional education, research, and improvements in patient care. These activities can encourage the adoption of new treatment approaches and help healthcare professionals stay informed about advances in radiation oncology.

Europe

Europe is an important market supported by advanced medical facilities, research infrastructure, and public-sector initiatives. Investment in specialist cancer centers and proton therapy facilities has helped expand access to advanced treatment options in parts of the region. Collaboration among healthcare institutions and professional organizations also supports research, education, and clinical development. The report identifies Europe as the fastest-growing region over the forecast period.

Asia-Pacific

Asia-Pacific is expected to experience significant growth as cancer-care demand rises and healthcare infrastructure expands. Countries such as China and India are investing in treatment facilities and advanced medical technologies. Growing awareness of cancer treatment options and the development of specialized hospitals may support greater use of radiotherapy. Continued investment in equipment, workforce training, and access to treatment will be important for sustaining regional growth.

Latin America, Middle East, and Africa

In Latin America, cancer incidence and the need for timely diagnosis and treatment create demand for improved radiotherapy services. International support and investment in cancer-care infrastructure can help expand access. In the Middle East and Africa, healthcare modernization, partnerships between technology providers and hospitals, and training initiatives may support the adoption of radiation oncology systems. However, differences in funding, infrastructure, and specialist availability can influence the pace of development across these regions.

Key Players in the Radiation Oncology Market

Major companies identified in the market report include:

• Varian Medical Systems Inc.
• IBA Radiopharma Solutions
• Elekta AB
• Accuray Incorporated
• BD
• Isoray Medical
• Nordion Inc.
• Mevion Medical Systems Inc.
• Curium Pharma
• ViewRay Technologies Inc.

These companies operate in areas related to radiation delivery, oncology systems, and associated medical technologies. Competition is shaped by product performance, treatment precision, reliability, clinical workflow integration, service support, and innovation. Companies that develop advanced systems and support healthcare providers with installation, training, and maintenance may be positioned to address evolving clinical needs.

Conclusion

The radiation oncology market is expected to expand as demand for cancer treatment increases and healthcare providers invest in advanced radiotherapy technologies. External beam radiation therapy, image-guided treatment, intensity-modulated radiation therapy, stereotactic approaches, and proton therapy contribute to the development of the market. At the same time, high equipment costs and shortages of skilled professionals remain important challenges. Continued technological innovation, infrastructure investment, and workforce training will be essential to improving access to radiation oncology services worldwide.

Source: Straits Research – Radiation Oncology Market

About Straits Research